Patent classifications
A61K36/71
Traditional Chinese medicine composition and preparation method and application thereof
A traditional Chinese medicine composition, made from cassia twig, poria, Cortex moutan, Radix paeoniae alba, peach kernel in equal proportions. The traditional Chinese medicine composition comprises paeoniflorin, amygdalin, benzoylpaeoniflorin, cinnamic acid, paeonol, and cinnamaldehyde. The composition has the advantages of high production efficiency, high content of effective ingredients, high transfer rate of poria acid, reduced hygroscopicity, and improved dissolution of index ingredients.
Traditional Chinese medicine composition and preparation method and application thereof
A traditional Chinese medicine composition, made from cassia twig, poria, Cortex moutan, Radix paeoniae alba, peach kernel in equal proportions. The traditional Chinese medicine composition comprises paeoniflorin, amygdalin, benzoylpaeoniflorin, cinnamic acid, paeonol, and cinnamaldehyde. The composition has the advantages of high production efficiency, high content of effective ingredients, high transfer rate of poria acid, reduced hygroscopicity, and improved dissolution of index ingredients.
NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEINS
Combinations of cannabinoids, vitamins, trace elements, bioactive components, bioflavonoid polyphenols, proteolytic enzymes, amino acids, and antioxidants which work independently and synergistically for the prevention, treatment, and inhibition of excess cytokines caused by the immune response to extreme viral and bacterial infections, including the inhibition of COVID-19, Rhinovirus and/or other virus spike proteins and mRNA vaccine spike proteins from attaching to body organ cells, penetrating cell membranes, and the replication of virus particles and spike proteins inside the cells. Inhibition of inflammation and prevention of long-term side effects, health issues (long-haulers), and disease caused by the SARS-CoV-2 and its variants, Rhinovirus, other viruses, bacteria, and mRNA vaccines are provided by the nutraceutical compositions. Specific combinations of these compounds work synergistically to increase the efficacy of the independent nutraceuticals in treatment.
NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEINS
Combinations of cannabinoids, vitamins, trace elements, bioactive components, bioflavonoid polyphenols, proteolytic enzymes, amino acids, and antioxidants which work independently and synergistically for the prevention, treatment, and inhibition of excess cytokines caused by the immune response to extreme viral and bacterial infections, including the inhibition of COVID-19, Rhinovirus and/or other virus spike proteins and mRNA vaccine spike proteins from attaching to body organ cells, penetrating cell membranes, and the replication of virus particles and spike proteins inside the cells. Inhibition of inflammation and prevention of long-term side effects, health issues (long-haulers), and disease caused by the SARS-CoV-2 and its variants, Rhinovirus, other viruses, bacteria, and mRNA vaccines are provided by the nutraceutical compositions. Specific combinations of these compounds work synergistically to increase the efficacy of the independent nutraceuticals in treatment.
A PRODUCING DEVICE AND PREPARING PROCESS OF A BLACK PLASTER
The present invention provides a black plaster producing device that comprises a workbench, longitudinal supports, a transverse bottom plate, an electric-heated thermostatic drying oven, and a storage rack structure for classified storage, a storage bucket, a stove, a boiling furnace, a furnace cover, a stirring box, a box cover, a stirring motor, a stirring pipe, a crushing blade, an adjustable partition frame structure, a rolling frame structure, a gas inlet pipe, a pipe valve, a stirring switch, a rolling switch and a receiving bucket, wherein the longitudinal supports are welded at four corners at the lower part of the workbench respectively, and the transverse bottom plate is screwed at the lower part of the longitudinal supports on the inner side. The transverse partition plate of the present invention is screwed at the central position inside the storage box, which facilitates the convenient storage of materials in the storage box during use and can classify the stored materials at the same time. The semiconductor refrigerating chip is screwed on the rear side of the inner wall at the lower part of the storage box, which facilitates the refrigeration and preservation of the materials stored at the bottom of the storage box on the inner side during use.
A PRODUCING DEVICE AND PREPARING PROCESS OF A BLACK PLASTER
The present invention provides a black plaster producing device that comprises a workbench, longitudinal supports, a transverse bottom plate, an electric-heated thermostatic drying oven, and a storage rack structure for classified storage, a storage bucket, a stove, a boiling furnace, a furnace cover, a stirring box, a box cover, a stirring motor, a stirring pipe, a crushing blade, an adjustable partition frame structure, a rolling frame structure, a gas inlet pipe, a pipe valve, a stirring switch, a rolling switch and a receiving bucket, wherein the longitudinal supports are welded at four corners at the lower part of the workbench respectively, and the transverse bottom plate is screwed at the lower part of the longitudinal supports on the inner side. The transverse partition plate of the present invention is screwed at the central position inside the storage box, which facilitates the convenient storage of materials in the storage box during use and can classify the stored materials at the same time. The semiconductor refrigerating chip is screwed on the rear side of the inner wall at the lower part of the storage box, which facilitates the refrigeration and preservation of the materials stored at the bottom of the storage box on the inner side during use.
Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland
A phytotherapeutic product for treatment of fibrocystic changes of mammary gland.
Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland
A phytotherapeutic product for treatment of fibrocystic changes of mammary gland.
A HERBO-MINERAL METALLIC PHARMACEUTICAL KIT
The present disclosure relates to a herbo-mineral metallic pharmaceutical kit and a process for its preparation. The herbo-mineral metallic pharmaceutical kit comprises Suvarna Bhasmadi Vati (SBV), Mouktikyukta Kamdudha Vati (MKV), Trailokyachintamani Rasa Vati (TCR), Kumari Kalpa Vati (KKV) and Khadirarishta (KHA). The herbo-mineral metallic pharmaceutical kit of the present disclosure can be used for delaying and/or controlling the recurrence or occurrence of breast and/or ovarian cancer in second breast and/or ovary or metastasis. The herbo-mineral metallic pharmaceutical compositions of the kit assist in reducing oxidative stress, improving immune status and quality of life and maintaining a disease-free survival in patients who are genetically predisposed to breast or ovarian cancer.
A HERBO-MINERAL METALLIC PHARMACEUTICAL KIT
The present disclosure relates to a herbo-mineral metallic pharmaceutical kit and a process for its preparation. The herbo-mineral metallic pharmaceutical kit comprises Suvarna Bhasmadi Vati (SBV), Mouktikyukta Kamdudha Vati (MKV), Trailokyachintamani Rasa Vati (TCR), Kumari Kalpa Vati (KKV) and Khadirarishta (KHA). The herbo-mineral metallic pharmaceutical kit of the present disclosure can be used for delaying and/or controlling the recurrence or occurrence of breast and/or ovarian cancer in second breast and/or ovary or metastasis. The herbo-mineral metallic pharmaceutical compositions of the kit assist in reducing oxidative stress, improving immune status and quality of life and maintaining a disease-free survival in patients who are genetically predisposed to breast or ovarian cancer.